Monash University
Browse

Novel inhibitors of Leishmania donovani for the treatment of Visceral Leishmaniasis

Download (17.82 MB)
thesis
posted on 2021-07-26, 00:50 authored by Nicole McNamara
Visceral leishmaniasis is a parasitic endemic caused by the protozoan parasite, Leishmania donovani. Parasites are transmitted to humans via infected sandflies, and can spread to visceral organs, causing eventual death. Current treatments remain unsuitable, due to severe side effects and building resistance. This project involved the design, synthesis, and successful optimization of novel chemical entities developed to strongly inhibit Leishmania parasites, whilst maintaining low toxicity against mammalian cells. Understanding which structural chemical modifications caused favourable potency was key to developing new lead compounds. Compounds were also designed possess drug-like properties, and overall aimed to guide future studies for drug development.

History

Campus location

Australia

Principal supervisor

Jonathan Baell

Additional supervisor 1

Malcolm McConville

Year of Award

2021

Department, School or Centre

Medicinal Chemistry

Course

Doctor of Philosophy

Degree Type

DOCTORATE

Faculty

Faculty of Pharmacy and Pharmaceutical Sciences